Pages that link to "Q24634622"
Jump to navigation
Jump to search
The following pages link to A critical role for ceramide synthase 2 in liver homeostasis: II. insights into molecular changes leading to hepatopathy (Q24634622):
Displaying 50 items.
- ELOVL1 production of C24 acyl-CoAs is linked to C24 sphingolipid synthesis (Q24302388) (← links)
- Ceramide synthases at the centre of sphingolipid metabolism and biology (Q24609859) (← links)
- Mammalian ceramide synthases (Q24633453) (← links)
- Ceramide-induced apoptosis in renal tubular cells: a role of mitochondria and sphingosine-1-phoshate (Q26822419) (← links)
- The complexity of sphingolipid biosynthesis in the endoplasmic reticulum (Q26823045) (← links)
- On the future of mass-spectrometry-based lipidomics (Q27012927) (← links)
- Nogo-B regulates endothelial sphingolipid homeostasis to control vascular function and blood pressure (Q27315147) (← links)
- Autophagy regulates sphingolipid levels in the liver (Q28115515) (← links)
- Ceramide induced mitophagy and tumor suppression (Q28384389) (← links)
- Ceramide as a mediator of non-alcoholic Fatty liver disease and associated atherosclerosis (Q28547365) (← links)
- Re-configuration of sphingolipid metabolism by oncogenic transformation (Q33649823) (← links)
- Ceramide synthesis regulates T cell activity and GVHD development (Q33703218) (← links)
- A critical role for ceramide synthase 2 in liver homeostasis: I. alterations in lipid metabolic pathways (Q33796283) (← links)
- Sphingosine kinase 1 in cancer (Q33853998) (← links)
- Nanotube action between human mesothelial cells reveals novel aspects of inflammatory responses (Q34117684) (← links)
- Dual functions of the trans-2-enoyl-CoA reductase TER in the sphingosine 1-phosphate metabolic pathway and in fatty acid elongation (Q34138890) (← links)
- A gene variant in CERS2 is associated with rate of increase in albuminuria in patients with diabetes from ONTARGET and TRANSCEND. (Q34215485) (← links)
- Metabolism of very long-chain Fatty acids: genes and pathophysiology (Q34416437) (← links)
- Reduced ceramide synthase 2 activity causes progressive myoclonic epilepsy (Q34418788) (← links)
- Distribution and functions of sterols and sphingolipids (Q35006514) (← links)
- Renal sulfatides: sphingoid base-dependent localization and region-specific compensation of CerS2-dysfunction. (Q35286905) (← links)
- Encephalopathy caused by ablation of very long acyl chain ceramide synthesis may be largely due to reduced galactosylceramide levels (Q35314176) (← links)
- Sphingolipid and glycosphingolipid metabolic pathways in the era of sphingolipidomics (Q35324757) (← links)
- Hepatic fatty acid uptake is regulated by the sphingolipid acyl chain length. (Q35522279) (← links)
- Plasma phospholipid very-long-chain saturated fatty acids and incident diabetes in older adults: the Cardiovascular Health Study (Q35537840) (← links)
- Ablation of ceramide synthase 2 strongly affects biophysical properties of membranes (Q35747763) (← links)
- Serum Sphingolipid Variations Associate with Hepatic Decompensation and Survival in Patients with Cirrhosis (Q35780081) (← links)
- Expression of Ceramide Synthase 6 Transcriptionally Activates Acid Ceramidase in a c-Jun N-terminal Kinase (JNK)-dependent Manner (Q35860939) (← links)
- The Impact of Ischemia/Reperfusion Injury on Liver Allografts from Deceased after Cardiac Death versus Deceased after Brain Death Donors (Q35919682) (← links)
- It's a lipid's world: bioactive lipid metabolism and signaling in neural stem cell differentiation (Q35931476) (← links)
- Cardiomyocyte specific deficiency of serine palmitoyltransferase subunit 2 reduces ceramide but leads to cardiac dysfunction (Q36002934) (← links)
- Glycosphingolipids and cell death: one aim, many ways (Q36405917) (← links)
- Ablation of ceramide synthase 2 causes chronic oxidative stress due to disruption of the mitochondrial respiratory chain (Q36620822) (← links)
- Ceramide Synthase 5 Is Essential to Maintain C16:0-Ceramide Pools and Contributes to the Development of Diet-induced Obesity (Q36727429) (← links)
- Serum sphingolipidomic analyses reveal an upregulation of C16-ceramide and sphingosine-1-phosphate in hepatocellular carcinoma (Q37109693) (← links)
- Protection of a ceramide synthase 2 null mouse from drug-induced liver injury: role of gap junction dysfunction and connexin 32 mislocalization (Q37312126) (← links)
- Altering the sphingolipid acyl chain composition prevents LPS/GLN-mediated hepatic failure in mice by disrupting TNFR1 internalization (Q37357098) (← links)
- Role of Intracellular Lipid Logistics in the Preferential Usage of Very Long Chain-Ceramides in Glucosylceramide (Q37377548) (← links)
- Pharmacogenetics of resistance to Cisplatin and other anticancer drugs and the role of sphingolipid metabolism (Q37705582) (← links)
- Sphingolipids and expression regulation of genes in cancer. (Q37802552) (← links)
- p53 and regulation of bioactive sphingolipids (Q37805092) (← links)
- Sphingolipids and cancer: ceramide and sphingosine-1-phosphate in the regulation of cell death and drug resistance (Q37808219) (← links)
- Ceramide-orchestrated signalling in cancer cells. (Q38067062) (← links)
- Human genetic disorders of sphingolipid biosynthesis (Q38241672) (← links)
- Sphingolipids and mitochondrial apoptosis (Q38332040) (← links)
- Ceramide synthases in mammalians, worms, and insects: emerging schemes (Q38472485) (← links)
- Genome-wide studies to identify risk factors for kidney disease with a focus on patients with diabetes (Q38553917) (← links)
- The 3-hydroxyacyl-CoA dehydratases HACD1 and HACD2 exhibit functional redundancy and are active in a wide range of fatty acid elongation pathways. (Q38695571) (← links)
- Compounds of the sphingomyelin-ceramide-glycosphingolipid pathways as secondary messenger molecules: new targets for novel therapies for fatty liver disease and insulin resistance (Q38833111) (← links)
- Defective ceramide synthases in mice cause reduced amplitudes in electroretinograms and altered sphingolipid composition in retina and cornea (Q38880061) (← links)